Cargando…

PCSK9 genetic variants and cognitive abilities: a large-scale Mendelian randomization study

INTRODUCTION: PCSK9 inhibitors lower low-density lipoprotein (LDL) cholesterol and are efficacious at reducing vascular disease, however questions remain about potential effects on cognitive function. METHODS: We examined the association of genetic variants in PCSK9 with continuous measures of cogni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lyall, Donald M., Ward, Joey, Banach, Maciej, Smith, George Davey, Gill, Jason G., Pell, Jill P., Holmes, Michael V., Sattar, Naveed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811317/ https://www.ncbi.nlm.nih.gov/pubmed/33488877 http://dx.doi.org/10.5114/aoms/127226

Ejemplares similares

Investigating the potential impact of PCSK9-inhibitors on mood disorders using eQTL-based Mendelian randomization
por: Aman, Alisha, et al.
Publicado: (2022)

Genetic analysis of the PCSK9 locus in psychological, psychiatric, metabolic and cardiovascular traits in UK Biobank
por: Hay, Rachel, et al.
Publicado: (2022)

PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
por: Schmidt, Amand F, et al.
Publicado: (2017)

The effect of PCSK9 immunization on the hepatic level of microRNAs associated with the PCSK9/LDLR pathway
por: Ataei, Sarina, et al.
Publicado: (2023)

Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study
por: Fang, Si, et al.
Publicado: (2023)

Impact of PCSK9 Immunization on Glycemic Indices in Diabetic Rats
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2021)

Effects of immunisation against PCSK9 in mice bearing melanoma
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2019)

Cannabis use and risk of schizophrenia: a Mendelian randomization study
por: Vaucher, J, et al.
Publicado: (2018)

Testing for association between exonic glucagon‐like peptide 1 receptor mutation with physical and brain health traits in UK Biobank
por: Ward, Joey, et al.
Publicado: (2022)

Associations between single and multiple cardiometabolic diseases and cognitive abilities in 474 129 UK Biobank participants
por: Lyall, Donald M., et al.
Publicado: (2017)

Effects of immunization against PCSK9 in an experimental model of breast cancer
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2019)

Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2019)

PCSK9 immunization using nanoliposomes: preventive efficacy against hypercholesterolemia and atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2021)

Genetic variations in HMGCR and PCSK9 and kidney function: a Mendelian randomization study
por: Park, Sehoon, et al.
Publicado: (2023)

Retraction Note: Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2023)

The association between coffee and caffeine consumption and renal function: insight from individual-level data, Mendelian randomization, and meta-analysis
por: Mazidi, Mohsen, et al.
Publicado: (2021)

Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment
por: Sliz, Eeva, et al.
Publicado: (2018)

LDL‐cholesterol and PCSK9 in patients with familial hypercholesterolemia: influence of PCSK9 variants under lipid‐lowering therapy
por: Hamasaki, Masato, et al.
Publicado: (2021)

Pre-Clinical Evaluation of the Nanoliposomal antiPCSK9 Vaccine in Healthy Non-Human Primates
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2021)

Impact of bariatric surgery on circulating PCSK9 levels as a marker of cardiovascular disease risk: a meta-analysis
por: Jamialahmadi, Tannaz, et al.
Publicado: (2022)

Characteristics of rheumatoid arthritis and its association with major comorbid conditions: cross-sectional study of 502 649 UK Biobank participants
por: Siebert, Stefan, et al.
Publicado: (2016)

Differential effects of PCSK9 loss of function variants on serum lipid and PCSK9 levels in Caucasian and African Canadian populations
por: Mayne, Janice, et al.
Publicado: (2013)

Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9
por: Schmidt, Amand F., et al.
Publicado: (2019)

Potential anti-tumor effect of a nanoliposomal antiPCSK9 vaccine in mice bearing colorectal cancer
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2019)

Common and Rare PCSK9 Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study
por: Hsu, Lung-An, et al.
Publicado: (2022)

Exploring PCSK9 Genetic Impact on Lipoprotein(a) via Dual Approaches: Association and Mendelian Randomization
por: Chang, Ya-Ching, et al.
Publicado: (2023)

PCSK9 Variants in Familial Hypercholesterolemia: A Comprehensive Synopsis
por: Guo, Qianyun, et al.
Publicado: (2020)

Association between APOE e4 and white matter hyperintensity volume, but not total brain volume or white matter integrity
por: Lyall, Donald M., et al.
Publicado: (2019)

Inclisiran—Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9
por: Wołowiec, Łukasz, et al.
Publicado: (2023)

Causal relationship between PCSK9 inhibitor and autoimmune diseases: a drug target Mendelian randomization study
por: Xie, Weijia, et al.
Publicado: (2023)

FOURIER & PCSK9 RNAi: Towards enhancing durability and efficacy of PCSK9 inhibitors
por: Hassan, Mohamed
Publicado: (2017)

The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol
por: Seidah, Nabil G.
Publicado: (2017)

BMI and Mortality in UK Biobank: Revised Estimates Using Mendelian Randomization
por: Wade, Kaitlin H., et al.
Publicado: (2018)

A Systematic Approach to Assess the Activity and Classification of PCSK9 Variants
por: Uribe, Kepa B., et al.
Publicado: (2021)

γGT and PCSK9 variants in subjects with hyper-LDL-cholesterolemia
por: Hamasaki, Masato, et al.
Publicado: (2022)

The Multifaceted Biology of PCSK9
por: Seidah, Nabil G, et al.
Publicado: (2021)

Child maltreatment and cardiovascular disease: quantifying mediation pathways using UK Biobank
por: Ho, Frederick K., et al.
Publicado: (2020)

Assessing the Impact of PCSK9 and HMGCR Inhibition on Liver Function: Drug-Target Mendelian Randomization Analyses in Four Ancestries
por: Rosoff, Daniel B., et al.
Publicado: (2023)

Association of injury related hospital admissions with commuting by bicycle in the UK: prospective population based study
por: Welsh, Claire, et al.
Publicado: (2020)

The associations of sugar-sweetened, artificially sweetened and naturally sweet juices with all-cause mortality in 198,285 UK Biobank participants: a prospective cohort study
por: Anderson, Jana J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0rcc6bo8otpt3vjebi8hm55hf0